These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30688042)

  • 41. Immunohistochemical and Immunocytochemical Analyses in Patients with Vitreoretinal Lymphoma.
    Kase S; Namba K; Kanno-Okada H; Onozawa M; Hidaka D; Iwata D; Mizuuchi K; Fukuhara T; Fukuhara J; Kitaichi N; Matsuno Y; Ishida S
    Ocul Immunol Inflamm; 2020; 28(1):147-155. PubMed ID: 30335535
    [No Abstract]   [Full Text] [Related]  

  • 42. Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy.
    Gozzi F; Aldigeri R; Mastrofilippo V; De Simone L; Bolletta E; Marzano J; Iannetta D; Coassin M; Ilariucci F; Ferrari A; Luminari S; Merli F; Croci S; Zerbini A; Farnetti E; Nicoli D; Valli R; Tamagnini I; Cavazza A; Salvarani C; Fontana L; Cimino L
    Ocul Immunol Inflamm; 2022; 30(7-8):1833-1841. PubMed ID: 34379571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. More Accurate Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results: A Prospective Observational Study.
    Tanaka R; Kaburaki T; Taoka K; Karakawa A; Tsuji H; Nishikawa M; Yatomi Y; Shinozaki-Ushiku A; Ushiku T; Araki F
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1354-1360. PubMed ID: 33793360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis.
    Minezaki T; Usui Y; Asakage M; Takanashi M; Shimizu H; Nezu N; Narimatsu A; Tsubota K; Umazume K; Yamakawa N; Kuroda M; Goto H
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze.
    Marchese A; Miserocchi E; Giuffrè C; Cicinelli MV; Querques G; Bandello F; Modorati G
    Br J Ophthalmol; 2019 Nov; 103(11):1656-1659. PubMed ID: 30709808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unilateral atypical fundus lesions with slow progression.
    Karma A; Immonen I; Laatikainen L
    Acta Ophthalmol Scand; 1999 Jun; 77(3):359-63. PubMed ID: 10406166
    [No Abstract]   [Full Text] [Related]  

  • 47. Diagnostic Accuracy of Vitreous Cytology in Patients with Vitreoretinal Lymphoma.
    Lee D; Lee J; Nahm JH; Kim M
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytological diagnosis of vitreoretinal lymphomas: A case series.
    Quintyn JC; Olle P; Courtade-Saidi M; Laurent C; Obéric L; Quintyn-Ranty ML
    Cytopathology; 2019 Jul; 30(4):385-392. PubMed ID: 31033057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
    Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates.
    Bonzheim I; Giese S; Deuter C; Süsskind D; Zierhut M; Waizel M; Szurman P; Federmann B; Schmidt J; Quintanilla-Martinez L; Coupland SE; Bartz-Schmidt KU; Fend F
    Blood; 2015 Jul; 126(1):76-9. PubMed ID: 25900979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical utility of cytokine analysis in the diagnosis and efficacy monitoring of vitreoretinal lymphoma.
    Kang H; Tao Y
    Int J Ophthalmol; 2022; 15(12):1893-1902. PubMed ID: 36536977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma.
    Kakkassery V; Schroers R; Coupland SE; Wunderlich MI; Schargus M; Heinz C; Wasmuth S; Heiligenhaus A; Ahle G; Lenoble P; Schlegel U; Schmiegel W; Dick HB; Baraniskin A
    Blood; 2017 Jun; 129(23):3130-3133. PubMed ID: 28389463
    [No Abstract]   [Full Text] [Related]  

  • 55. Two cases of primary vitreoretinal lymphoma: a diagnostic challenge : The supporting role of multimodal imaging in the diagnosis of primary vitreoretinal lymphoma.
    Morara M; Foschi F; Veronese C; Torrazza C; Bacci F; Stefoni V; Ciardella PA
    Int Ophthalmol; 2018 Feb; 38(1):353-361. PubMed ID: 28039672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
    Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
    Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
    Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
    Levasseur SD; Wittenberg LA; White VA
    JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
    Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
    Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PreservCyt Is an Optimal Fixative that Permits Cytologic and Molecular Analyses of Vitreoretinal Lymphoma Biopsies.
    Wang MM; Tan WJ; Lim TS; Chan ASY
    Ocul Immunol Inflamm; 2021 Apr; 29(3):430-439. PubMed ID: 31418635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.